JP2010512747A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512747A5 JP2010512747A5 JP2009541384A JP2009541384A JP2010512747A5 JP 2010512747 A5 JP2010512747 A5 JP 2010512747A5 JP 2009541384 A JP2009541384 A JP 2009541384A JP 2009541384 A JP2009541384 A JP 2009541384A JP 2010512747 A5 JP2010512747 A5 JP 2010512747A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- isolated nucleic
- seq
- molecule according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86993706P | 2006-12-14 | 2006-12-14 | |
| PCT/US2007/025535 WO2008076324A2 (en) | 2006-12-14 | 2007-12-13 | Compositions and methods to treat muscular & cardiovascular disorders |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011178297A Division JP2012019789A (ja) | 2006-12-14 | 2011-08-17 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
| JP2012034691A Division JP2012131812A (ja) | 2006-12-14 | 2012-02-21 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010512747A JP2010512747A (ja) | 2010-04-30 |
| JP2010512747A5 true JP2010512747A5 (enExample) | 2011-02-03 |
Family
ID=39536897
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009541384A Withdrawn JP2010512747A (ja) | 2006-12-14 | 2007-12-13 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
| JP2011178297A Withdrawn JP2012019789A (ja) | 2006-12-14 | 2011-08-17 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
| JP2012034691A Withdrawn JP2012131812A (ja) | 2006-12-14 | 2012-02-21 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011178297A Withdrawn JP2012019789A (ja) | 2006-12-14 | 2011-08-17 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
| JP2012034691A Withdrawn JP2012131812A (ja) | 2006-12-14 | 2012-02-21 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20100280094A1 (enExample) |
| EP (1) | EP2104733A2 (enExample) |
| JP (3) | JP2010512747A (enExample) |
| KR (1) | KR20090098818A (enExample) |
| CN (2) | CN102604951A (enExample) |
| AU (1) | AU2007334502B2 (enExample) |
| BR (1) | BRPI0719995A2 (enExample) |
| CA (1) | CA2672606A1 (enExample) |
| EA (2) | EA201101361A1 (enExample) |
| MX (1) | MX2009006310A (enExample) |
| WO (1) | WO2008076324A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007281261B2 (en) | 2006-08-01 | 2013-03-21 | Board Of Regents Of The University Of Texas System | Identification of a micro-RNA that activates expression of beta-myosin heavy chain |
| EP2187896B1 (en) | 2007-07-31 | 2016-01-13 | The Board of Regents of The University of Texas System | Inhibitors of mir-499 and mir-208b for use in the treatment of pathologic cardiac hypertrophy, heart failure or myocardial infarction |
| RU2515926C2 (ru) | 2009-02-04 | 2014-05-20 | Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем | Двойное нацеливание нп mir-208 и mir 499 в лечении заболеваний сердца |
| IE20090047A1 (en) * | 2009-02-26 | 2010-09-29 | Nat Univ Ireland | Protein targets in disease |
| AU2010224100B2 (en) | 2009-03-12 | 2015-10-22 | Brandeis University | Reagents and methods for PCR |
| KR20140004646A (ko) | 2010-12-15 | 2014-01-13 | 미라젠 세러퓨틱스 | 잠금 뉴클레오티드를 포함하는 마이크로rna 억제제 |
| KR20140091688A (ko) | 2011-10-06 | 2014-07-22 | 미라젠 세러퓨틱스 인코포레이티드 | 마이크로rna 조절에 의한 전신 에너지 항상성의 제어 |
| CN107236735B (zh) | 2012-06-21 | 2019-11-08 | 米拉根医疗股份有限公司 | 包含锁核酸基序的基于寡核苷酸的抑制剂 |
| CN104968783B (zh) | 2012-10-15 | 2019-12-10 | Ionis制药公司 | 用于调节c9orf72表达的组合物 |
| EP2906697A4 (en) | 2012-10-15 | 2016-06-22 | Ionis Pharmaceuticals Inc | METHOD FOR MONITORING THE C9ORF72 EXPRESSION |
| US9637738B2 (en) * | 2013-04-10 | 2017-05-02 | Reveragen Biopharma, Inc. | Methods and agents to increase therapeutic dystrophin expression in muscle |
| US10221414B2 (en) | 2013-10-11 | 2019-03-05 | Ionis Pharmaceuticals, Inc. | Compositions for modulating C9ORF72 expression |
| CA2957618A1 (en) * | 2014-08-04 | 2016-02-11 | MiRagen Therapeutics, Inc. | Inhibitors of myh7b and uses thereof |
| EP3247716A4 (en) | 2015-01-20 | 2018-10-17 | Miragen Therapeutics, Inc. | Mir-92 inhibitors and uses thereof |
| RS60230B1 (sr) | 2015-04-16 | 2020-06-30 | Ionis Pharmaceuticals Inc | Kompozicije za moduliranje ekspresije c9orf72 |
| WO2017079291A1 (en) | 2015-11-02 | 2017-05-11 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulating c90rf72 |
| CN106148519A (zh) * | 2016-07-05 | 2016-11-23 | 无锡市第二人民医院 | 一种microRNA‑499的快速检测方法 |
| WO2019014656A1 (en) | 2017-07-14 | 2019-01-17 | Han Si Ping | METALLIC OLIGONUCLEOTIDE JONCTIONS FOR THE ADMINISTRATION OF THERAPEUTIC AGENTS |
| WO2019033079A1 (en) | 2017-08-10 | 2019-02-14 | City Of Hope | CONDITIONAL RNAIDS AND THEIR USES IN THE TREATMENT OF CARDIAC HYPERTROPHY |
| KR102281710B1 (ko) | 2021-02-19 | 2021-07-28 | 조기정 | 에어튜브를 이용한 선박 안전장치 |
| CN119246849B (zh) * | 2024-12-09 | 2025-03-14 | 上海基灵生物科技有限公司 | 一种检测犬心脏损伤的试剂盒及应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5602240A (en) * | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
| US5489677A (en) * | 1990-07-27 | 1996-02-06 | Isis Pharmaceuticals, Inc. | Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms |
| MY107332A (en) * | 1990-08-03 | 1995-11-30 | Sterling Drug Inc | Compounds and methods for inhibiting gene expression. |
| US5719262A (en) * | 1993-11-22 | 1998-02-17 | Buchardt, Deceased; Ole | Peptide nucleic acids having amino acid side chains |
| US5700922A (en) * | 1991-12-24 | 1997-12-23 | Isis Pharmaceuticals, Inc. | PNA-DNA-PNA chimeric macromolecules |
| JP3516167B2 (ja) * | 1992-12-08 | 2004-04-05 | ローム株式会社 | タンタルコンデンサチップの製造方法 |
| US6271359B1 (en) * | 1999-04-14 | 2001-08-07 | Musc Foundation For Research Development | Tissue-specific and pathogen-specific toxic agents and ribozymes |
| CA2429814C (en) * | 2000-12-01 | 2014-02-18 | Thomas Tuschl | Rna interference mediating small rna molecules |
| CA2532228C (en) * | 2003-07-16 | 2017-02-14 | Protiva Biotherapeutics, Inc. | Lipid encapsulated interfering rna |
| WO2005021800A2 (en) * | 2003-08-22 | 2005-03-10 | Sirna Therapeutics, Inc. | Detection and quantitation of nucleic acid molecules in biological samples |
| JP5697297B2 (ja) * | 2004-05-14 | 2015-04-08 | ロゼッタ ジノミクス リミテッド | マイクロｎａｓおよびその使用 |
| EP1877557A2 (en) * | 2005-04-04 | 2008-01-16 | The Board of Regents of The University of Texas System | Micro-rna's that regulate muscle cells |
| US20070092882A1 (en) * | 2005-10-21 | 2007-04-26 | Hui Wang | Analysis of microRNA |
| AU2007205326B2 (en) * | 2006-01-10 | 2013-08-22 | Koninklijke Nederlandse Akademie Van Wetenschappen | Nucleic acid molecules and collections thereof, their application and modification |
| AU2007281261B2 (en) * | 2006-08-01 | 2013-03-21 | Board Of Regents Of The University Of Texas System | Identification of a micro-RNA that activates expression of beta-myosin heavy chain |
| EP2187896B1 (en) * | 2007-07-31 | 2016-01-13 | The Board of Regents of The University of Texas System | Inhibitors of mir-499 and mir-208b for use in the treatment of pathologic cardiac hypertrophy, heart failure or myocardial infarction |
-
2007
- 2007-12-13 MX MX2009006310A patent/MX2009006310A/es not_active Application Discontinuation
- 2007-12-13 CN CN2012100499504A patent/CN102604951A/zh active Pending
- 2007-12-13 US US12/519,323 patent/US20100280094A1/en not_active Abandoned
- 2007-12-13 KR KR1020097012148A patent/KR20090098818A/ko not_active Withdrawn
- 2007-12-13 JP JP2009541384A patent/JP2010512747A/ja not_active Withdrawn
- 2007-12-13 CN CNA2007800464358A patent/CN101563458A/zh active Pending
- 2007-12-13 BR BRPI0719995-3A2A patent/BRPI0719995A2/pt not_active IP Right Cessation
- 2007-12-13 EA EA201101361A patent/EA201101361A1/ru unknown
- 2007-12-13 EA EA200900782A patent/EA200900782A1/ru unknown
- 2007-12-13 AU AU2007334502A patent/AU2007334502B2/en not_active Ceased
- 2007-12-13 WO PCT/US2007/025535 patent/WO2008076324A2/en not_active Ceased
- 2007-12-13 EP EP07867751A patent/EP2104733A2/en not_active Withdrawn
- 2007-12-13 CA CA002672606A patent/CA2672606A1/en not_active Abandoned
-
2011
- 2011-08-09 US US13/206,055 patent/US20120041052A1/en not_active Abandoned
- 2011-08-17 JP JP2011178297A patent/JP2012019789A/ja not_active Withdrawn
-
2012
- 2012-01-18 US US13/352,570 patent/US20120114744A1/en not_active Abandoned
- 2012-02-21 JP JP2012034691A patent/JP2012131812A/ja not_active Withdrawn